(2) Combined targeted therapy in lung cancer: In non-small cell lung cancer, the combined targeted therapy of MTFP1 and mitochondrial dynamics-related proteins (such as Drp1, OPA1, etc.)has shown significant anti-tumor effects. This evidence concerns the gene MTFP1 and neoplasm.